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m-CPI and CPI ROC curve analyses showed areas under the curves (AUCs)
of 0.68 (95% confidence interval (CI), 0.48-0.87; p  0.046), 0.66 (95%
CI, 0.51–0.81; p  0.067), 0.63 (95% CI, 0.45–0.81; p  0.148) and 0.65
(95% CI, 0.49–0.80; p  0.101) respectively. Corresponding AUCs for
prediction of morbidity were 0.64 (95% CI, 0.51–0.76; p  0.511), 0.62
(95% CI, 0.51–0.74; p  0.505), 0.54 (95% CI, 0.41–0.67; p  0.416)
and 0.55 (95% CI, 0.42–0.68; p  0.451).
Conclusions: GAS, V-POSSUM, m-CPI and CPI were poor predic-
tors of early mortality and morbidity following EVR in this series. Caution
should be applied to the use of these scoring systems for pre-operative risk
stratification and treatment selection for endovascular repair of abdominal
aneurysms.
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Objective: The aim of this study was to evaluate the early and mid term
outcom of patients with aortic graft infection who underwent in-situ revas-
cularisation with a silver coated prosthesis.
Material: From January 2000 to December 2006, 24 consecutive
patients (22 male, 2 female) with mean age 67 years were prospectively
entered in this study of aortic graft infection at our single centre. Infection
was managed with either total (n  19) or partial (n  5) excision of the
infected graft and in- situ reconstruction with a silver coated prosthesis, Inter
Gard Silver (IGSG).
Methods: The primary endpoint was recurrence of infection.
Secondary endpoints were early and late mortality, peri-operative
morbidity, primary graft patency, major amputation rates and patient
survival.
Results: Fourteen patients had a primary graft infection, however 10 of
24 patients had graft infection secondary to aorto digestive (n  9) or aorto
urinary (n  1) tract fistulas. Bacteriological cultures were negative in 8
(33%) patients.Most organisms cultivated where virulent and themajority of
graft infections were polymicrobial (71%). Silver grafts were placed emer-
gently in 6 (25%) patients. Mean follow up 32.5  31.0 months (range
2–78 months).
Peri-operative morbidity and mortality were 46% and 21% respectively.
Early interventions occurred in 6 (25%) patients and late secondary inter-
vention were required in 3 (15.7%), caused by silver graft reinfection. The
late mortality was 26%.
Conclusion: In-situ reconstruction with the silver graft confirms sim-
ilarity with other modalities. The greatest advantage for the silver graft is its
ease of use but the risk of reinfection remains significant.
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Purpose: It is unclear whether a residual sapheno-femoral stump left in
place after stripping of the great saphenous vein can contribute to the
formation of late inguinal varicose vein recurrence. In order to obtain
information about the time course of recurrence development, patients with
histologically proven residual stumps were recruited and asked about the
interval between the initial operation and the first clinical signs of varicose
vein recurrence.
Methods: A multi-centre study involving 7 centres was conducted
amongst patients undergoing redo-surgery for inguinal varicose vein
recurrences. The sapheno-femoral stumps resected during the redo-
surgery were classified histologically. Patients with a proven long residual
sapheno-femoral stump were asked to describe the first signs of varicose
vein recurrence with the help of a standardised questionnaire. From these
data the symptom-free interval, consisting of the time frame between the
initial operation and the first signs of recurrence, was determined.
Results: In 279 legs of 251 patients a long residual sapheno-femoral
stump was present. Most patients had experienced a symptom-free interval
after the initial operation with a mean duration of 7.4 S.D. 5.5 years.
Recurrent varicose veins became apparent after a mean time interval of 6.3
S.D. 5.3 years and congestion symptoms occurred after a mean interval of
8.5 S.D. 5.7 years.
Conclusions: In patients with symptomatic groin recurrences, a long
residual sapheno-femoral stump was found in about two thirds of cases. The
first clinical signs of varicose vein recurrence can be expected 7–8 years after
the initial treatment at the earliest. Long term follow up is required reliably
to asses the outcome of treatment for varicose veins.
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